393 related articles for article (PubMed ID: 32226528)
1. Serelaxin alleviates cardiac fibrosis through inhibiting endothelial-to-mesenchymal transition via RXFP1.
Wilhelmi T; Xu X; Tan X; Hulshoff MS; Maamari S; Sossalla S; Zeisberg M; Zeisberg EM
Theranostics; 2020; 10(9):3905-3924. PubMed ID: 32226528
[No Abstract] [Full Text] [Related]
2. AT1R-AT2R-RXFP1 Functional Crosstalk in Myofibroblasts: Impact on the Therapeutic Targeting of Renal and Cardiac Fibrosis.
Chow BSM; Kocan M; Shen M; Wang Y; Han L; Chew JY; Wang C; Bosnyak S; Mirabito-Colafella KM; Barsha G; Wigg B; Johnstone EKM; Hossain MA; Pfleger KDG; Denton KM; Widdop RE; Summers RJ; Bathgate RAD; Hewitson TD; Samuel CS
J Am Soc Nephrol; 2019 Nov; 30(11):2191-2207. PubMed ID: 31511361
[TBL] [Abstract][Full Text] [Related]
3. The anti-fibrotic actions of relaxin are mediated through AT
Wang C; Pinar AA; Widdop RE; Hossain MA; Bathgate RAD; Denton KM; Kemp-Harper BK; Samuel CS
FASEB J; 2020 Jun; 34(6):8217-8233. PubMed ID: 32297670
[TBL] [Abstract][Full Text] [Related]
4. Relaxin inhibits cardiac fibrosis and endothelial-mesenchymal transition via the Notch pathway.
Zhou X; Chen X; Cai JJ; Chen LZ; Gong YS; Wang LX; Gao Z; Zhang HQ; Huang WJ; Zhou H
Drug Des Devel Ther; 2015; 9():4599-611. PubMed ID: 26316699
[TBL] [Abstract][Full Text] [Related]
5. Localization of relaxin receptors in arteries and veins, and region-specific increases in compliance and bradykinin-mediated relaxation after in vivo serelaxin treatment.
Jelinic M; Leo CH; Post Uiterweer ED; Sandow SL; Gooi JH; Wlodek ME; Conrad KP; Parkington H; Tare M; Parry LJ
FASEB J; 2014 Jan; 28(1):275-87. PubMed ID: 24036884
[TBL] [Abstract][Full Text] [Related]
6. Serelaxin-mediated signal transduction in human vascular cells: bell-shaped concentration-response curves reflect differential coupling to G proteins.
Sarwar M; Samuel CS; Bathgate RA; Stewart DR; Summers RJ
Br J Pharmacol; 2015 Feb; 172(4):1005-19. PubMed ID: 25297987
[TBL] [Abstract][Full Text] [Related]
7. Serelaxin is a more efficacious antifibrotic than enalapril in an experimental model of heart disease.
Samuel CS; Bodaragama H; Chew JY; Widdop RE; Royce SG; Hewitson TD
Hypertension; 2014 Aug; 64(2):315-22. PubMed ID: 24866131
[TBL] [Abstract][Full Text] [Related]
8. Crosstalk between endothelial cell-specific calpain inhibition and the endothelial-mesenchymal transition via the HSP90/Akt signaling pathway.
Sun X; Sun Y; Jiang P; Qi G; Chen X
Biomed Pharmacother; 2020 Apr; 124():109822. PubMed ID: 31958767
[TBL] [Abstract][Full Text] [Related]
9. Increase of cortical cerebral blood flow and further cerebral microcirculatory effects of Serelaxin in a sheep model.
Bischoff SJ; Schmidt M; Lehmann T; Irintchev A; Schubert H; Jung C; Schwab M; Huber O; Matziolis G; Schiffner R
Am J Physiol Heart Circ Physiol; 2016 Sep; 311(3):H613-20. PubMed ID: 27402664
[TBL] [Abstract][Full Text] [Related]
10. Altered expression of RXFP1 receptor contributes to the inefficacy of relaxin-based anti-fibrotic treatments in systemic sclerosis.
Corallo C; Pinto AM; Renieri A; Cheleschi S; Fioravanti A; Cutolo M; Soldano S; Nuti R; Giordano N
Clin Exp Rheumatol; 2019; 37 Suppl 119(4):69-75. PubMed ID: 31365333
[TBL] [Abstract][Full Text] [Related]
11. Enhanced serelaxin signalling in co-cultures of human primary endothelial and smooth muscle cells.
Sarwar M; Samuel CS; Bathgate RA; Stewart DR; Summers RJ
Br J Pharmacol; 2016 Feb; 173(3):484-96. PubMed ID: 26493539
[TBL] [Abstract][Full Text] [Related]
12. Receptor-independent modulation of TGF-β-induced pro-fibrotic pathways by relaxin-2 in human primary tubular epithelial cells.
Grampp S; Goppelt-Struebe M
Cell Tissue Res; 2018 Dec; 374(3):619-627. PubMed ID: 30078103
[TBL] [Abstract][Full Text] [Related]
13. Serelaxin inhibits differentiation and fibrotic behaviors of cardiac fibroblasts by suppressing ALK-5/Smad2/3 signaling pathway.
Wu XP; Wang HJ; Wang YL; Shen HR; Tan YZ
Exp Cell Res; 2018 Jan; 362(1):17-27. PubMed ID: 28987540
[TBL] [Abstract][Full Text] [Related]
14. H3 relaxin demonstrates antifibrotic properties via the RXFP1 receptor.
Hossain MA; Man BC; Zhao C; Xu Q; Du XJ; Wade JD; Samuel CS
Biochemistry; 2011 Mar; 50(8):1368-75. PubMed ID: 21229994
[TBL] [Abstract][Full Text] [Related]
15. Calcitriol Attenuates Doxorubicin-Induced Cardiac Dysfunction and Inhibits Endothelial-to-Mesenchymal Transition in Mice.
Tsai TH; Lin CJ; Hang CL; Chen WY
Cells; 2019 Aug; 8(8):. PubMed ID: 31405028
[TBL] [Abstract][Full Text] [Related]
16. Altered Cerebral Blood Flow and Potential Neuroprotective Effect of Human Relaxin-2 (Serelaxin) During Hypoxia or Severe Hypovolemia in a Sheep Model.
Schiffner R; Bischoff SJ; Lehmann T; Irintchev A; Nistor M; Lemke C; Schmidt M
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32120997
[TBL] [Abstract][Full Text] [Related]
17. Human recombinant relaxin-2 does not attenuate hypertension or renal injury but exacerbates vascular dysfunction in a female mouse model of SLE.
Wolf VL; Phillips TL; Taylor EB; Sasser JM; Ryan MJ
Am J Physiol Heart Circ Physiol; 2019 Aug; 317(2):H234-H242. PubMed ID: 31125285
[TBL] [Abstract][Full Text] [Related]
18. Relaxin/serelaxin for cardiac dysfunction and heart failure in hypertension.
Chunduri P; Patel SA; Levick SP
Adv Pharmacol; 2022; 94():183-211. PubMed ID: 35659372
[TBL] [Abstract][Full Text] [Related]
19. Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial.
Snowdon VK; Lachlan NJ; Hoy AM; Hadoke PW; Semple SI; Patel D; Mungall W; Kendall TJ; Thomson A; Lennen RJ; Jansen MA; Moran CM; Pellicoro A; Ramachandran P; Shaw I; Aucott RL; Severin T; Saini R; Pak J; Yates D; Dongre N; Duffield JS; Webb DJ; Iredale JP; Hayes PC; Fallowfield JA
PLoS Med; 2017 Feb; 14(2):e1002248. PubMed ID: 28245243
[TBL] [Abstract][Full Text] [Related]
20. Serelaxin improves cardiac and renal function in DOCA-salt hypertensive rats.
Wang D; Luo Y; Myakala K; Orlicky DJ; Dobrinskikh E; Wang X; Levi M
Sci Rep; 2017 Aug; 7(1):9793. PubMed ID: 28851937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
